Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Strengthening Manufacturing in America through Responsible Transitions to Electric Act or the SMART Electric Act This bill directs the Department of Energy (DOE) to establish a program that provides rebates to industrial or manufacturing facilities, commercial buildings, or utilities or energy service companies for energy efficiency upgrades. Specifically, DOE may provide rebates for expenditures made by such entities for energy efficient electrotechnology that is used to replace a fossil fuel-fired technology.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2024 · fourth_quarter · Health Issues
Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure Prescription Drug Supply Chain issues Pharmacy benefit manager policies H.R.7635, The 340B PATIENTS Act of 2024, Entirety H.R.8574, 340B ACCESS Act, Entirety H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety The SUSTAIN 340B Act, Entirety 340B payment process issues 340B Reform related issues Telehealth related issues Native American health workforce development issues, generally FDA, Diagnostic Laboratory Testing issues Health Care Price Transparency H.$.5378, Lower Cost More Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Mental Health initiatives Center for Excellence in Improving Diagnosis legislation Surprise Billing Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Referred to the Subcommittee on Energy.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $60,000
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · fourth_quarter · Health Issues
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · third_quarter · Health Issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure Prescription Drug Supply Chain issues Pharmacy benefit manager policies H.R.7635, The 340B PATIENTS Act of 2024, Entirety H.R.8574, 340B ACCESS Act, Entirety H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, Entirety The SUSTAIN 340B Act, Entirety 340B payment process issues 340B Reform related issues Monitor the following: Native American health workforce development issues, generally FDA, Diagnostic Laboratory Testing issues Health Care Price Transparency H.$.5378, Lower Cost More Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Mental Health initiatives Center for Excellence in Improving Diagnosis legislation Surprise Billing Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medical/Disease Research/Clinical Labs
Monitor the following: FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
2024 · third_quarter · Health Issues
Monitor the following: FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Protecting Access to Medicare Act (PAMA), Cuts related issues H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
2024 · second_quarter · Health Issues
Native American health workforce development issues, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Monitor the following: 340B Reform related issues FDA, Diagnostic Laboratory Testing issues Health Care Price Transparency H.$.5378, Lower Cost More Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Mental Health initiatives Center for Excellence in Improving Diagnosis legislation Surprise Billing Prescription Drug Supply Chain issues Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2024 · second_quarter · Health Issues
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · second_quarter · Medical/Disease Research/Clinical Labs
FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2024 · first_quarter · Health Issues
340B Reform related issues FDA, Diagnostic Laboratory Testing issues Health Workforce Development issues, generally Health Care Price Transparency Monitor the following: H.$.5378, Lower Cost More Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation Surprise Billing Prescription Drug Supply Chain issues Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Client expense: Not reported · Firm income: $30,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Medicare reimbursement for diagnostics. HR.2369- VALID Act. Implementation of Inflation Reduction Act of 2022. Medicare Contractor Reform.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
340B Reform related issues H.R.3290, 340B Transparency Act, Entirety Monitor the following: H.$.5378, Lower Cost More Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation Surprise Billing Health Care Transparency Prescription Drug Supply Chain issues Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · fourth_quarter · Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues Monitor the following: H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Medicare reimbursement for diagnostics. HR.2369- VALID Act. Implementation of Inflation Reduction Act of 2022.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
H.R.5378, Lower Cost More Transparency Act, Entirety Monitor the following: H.R.3290, 340B Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues Surprise Billing Health Care Transparency Prescription Drug Supply Chain issues Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · third_quarter · Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medical/Disease Research/Clinical Labs
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
H.R.3290, 340B Transparency Act, Entirety Monitor the following: H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) CURES 2.0, Health services delivery; and Research and development issues ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · second_quarter · Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues Monitor the following: H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally CURES 2.0, Diagnostic Lab Testing issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · second_quarter · Medical/Disease Research/Clinical Labs
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues Monitor the following: H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally CURES 2.0, Diagnostic Lab Testing issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2023 · first_quarter · Health Issues
H.R.2369, the VALID Act, issues related to regulation of laboratory developed tests at academic clinical labs H.R.2584, the Safety from Violence for Healthcare Employees (SAVE) Act of 2022 Legislative proposals to improve access to behavioral health and pediatric behavioral health services Issues related to healthcare workforce needs and shortages. Issues related to pandemic preparedness and reauthorization of PAHPA. Issues related to the expansion of telehealth services. Transplant issues related to reforms of the OPTN and OPO performance. Issues related to hospital services and winddown of the COVID-19 PHE. Issues related to civilian-military trauma training programs. Promotion of the academic medicine caucus. Issues related to CDC domestic HIV/AIDS prevention programs.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Monitor the following: H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation 340B generally P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Coronavirus, Hospital and Healthcare Telehealth initiatives CURES 2.0, Health services delivery; and Research and development issues ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues
Client expense: Not reported · Firm income: $50,000
2023 · first_quarter · Health Issues
H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes, Diagnostic Lab Testing Laboratory Testing related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally Monitor CURES 2.0, Diagnostic Lab Testing issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Medical/Disease Research/Clinical Labs
H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes, Diagnostic Lab Testing Laboratory Testing related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally Monitor CURES 2.0, Diagnostic Lab Testing issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support industrial electrification and electrotechnologies; HR 2369, the SMART Electric Act; H.R. 5376 - the Inflation Reduction Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Energy/Nuclear
H.R.5376 Inflation Reduction Act of 2022 H.R. 2369- SMART Electric Act (not yet introduced) S. 1791 - FAST Electricity Act H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act S. 622- American Jobs in Energy Manufacturing Act of 2021 S. 2241 - RECHARGE Act (Hickenlooper) S.2140 - Solar Energy Manufacturing for America Act S.3112 Hydrogen for Industry Act of 2021 S.3111 Hydrogen for Ports Act of 2021 S.3118 Hydrogen Infrastructure Finance and Innovation Act Offshore Energy Modernization Act (not yet introduced) (Tonko) Economic Development Administration Reauthorization
Client expense: $10,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), White House Office
2022 · third_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support industrial electrification and electrotechnologies; HR 2369, the SMART Electric Act; H.R. 5376 - the Inflation Reduction Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Energy/Nuclear
Bennet Battery Bill (not yet introduced) H.R. 998 - Offshore Wind Jobs and Opportunity Act H.R. 2369- SMART Electric Act (not yet introduced) S. 1791 - FAST Electricity Act H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act H.R. 1817 - Community Transition Grants Act S. 2118 - Clean Energy for America Act (Plus parts to be reintroduced [45M incentive, etc.] in 117th) S. 622- American Jobs in Energy Manufacturing Act of 2021 S. 2241 - RECHARGE Act (Hickenlooper) S.2140 - Solar Energy Manufacturing for America Act S.3112 Hydrogen for Industry Act of 2021 S.3111 Hydrogen for Ports Act of 2021 S.3118 Hydrogen Infrastructure Finance and Innovation Act H.R. 5689 - RESILIENT America Act H.R. 6396 - Climate RESILIENCE Act Economic Development Administration Reauthorization
Client expense: $10,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), White House Office
2022 · second_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support electrification and electrotechnologies; HR 2369, the SMART Electric Act; Reconciliation bills including S. Con. Res. 14 and H.R.5376- the Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support electrification and electrotechnologies; HR 2369, the SMART Electric Act; Reconciliation bills including S. Con. Res. 14 and H.R.5376- the Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Energy/Nuclear
H.R. 998 - Offshore Wind Jobs and Opportunity Act H.R. 1636 - Postal Vehicle Modernization Act H.R. 2369- SMART Electric Act (not yet introduced) S. 1791 - FAST Electricity Act H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act H.R. 1817 - Community Transition Grants Act S. 2118 - Clean Energy for America Act (Plus parts to be reintroduced [45M incentive, etc.] in 117th) S. 622- American Jobs in Energy Manufacturing Act of 2021 S. 2241 - RECHARGE Act (Hickenlooper) S.2140 - Solar Energy Manufacturing for America Act S.3112 Hydrogen for Industry Act of 2021 S.3111 Hydrogen for Ports Act of 2021 S.3118 Hydrogen Infrastructure Finance and Innovation Act H.R.6546 Wireless EV Charging Innovation Act of 2021 (Brenda Lawrence) H.R.7018 Green Postal Service Fleet Act of 2022 (Committee on Oversight & Reform, Gerry Connolly) H.R. 5477 - Federal Agency Climate PREP Act H.R. ____ - Modern Mines Bill (Rep. Lamb - not yet introduced) H.R 7283/S. 3957 - STREAM Act: Safeguarding Treatment for the Restoration of Ecosystems from Abandoned Mines Act H.R. 5689 - RESILIENT America Act H.R. 6396 - Climate RESILIENCE Act
Client expense: $10,000 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), White House Office
2021 · fourth_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support electrification and electrotechnologies; HR 2369, the SMART Electric Act; Reconciliation bills including S. Con. Res. 14 and H.R.5376- the Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Energy/Nuclear
S.__. - advanced battery manufacturing investment credit and the advanced battery manufacturing production credit. - To be introduced H.R. 998 - Offshore Wind Jobs and Opportunity Act S. 508/ H.R. 1344 - Clean School Bus Act H.R. 2721/ S. 1271- Clean Commute for Kids Act H.R. 1636 - Postal Vehicle Modernization Act S._Sen. Schumer clean bus transit grants (not yet introduced) H.R. ___ - BATTERY Act (not yet reintroduced) H.R.2279 - Office of manufacturing and industrial innovation policy Act H.R. 2369- SMART Electric Act (not yet introduced) S. 1791 - FAST Electricity Act H.R. 2308 - Advanced Technology Vehicle Manufacturing (ATVM) Future Act Electric Drive Act (not yet introduced) H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act H.R. 1817 - Community Transition Grants Act H.R. 835 - Green Bus Tax Credit Act H.R. 698 - EV CHARGE Act (Doggett) H.R. ___ - Used EV Tax Credit Bill (not yet introduced) H.R. ___ - Driving America Forward Act (soon to be reintroduced in 117th Congress) S. 2118 - Clean Energy for America Act (Plus parts to be reintroduced [45M incentive, etc.] in 117th) S. 622- American Jobs in Energy Manufacturing Act of 2021 S. 2241 - RECHARGE Act (Hickenlooper) S.2140 - Solar Energy Manufacturing for America Act H.R.2263 - Manufacturing for Our Future Act S.2766 Offshore Wind American Manufacturing Act H.R. ____ Sustainable Industry Rebate Program (not yet introduced) S. ___ Hydrogen deployment grant programs (not yet introduced) S.1925 - Buy Green Act H.R. 5698: Manufacturing Assistance to Determine Emissions (MADE) Act (Rep. Lamb - not yet introduced) S. ____ - Buy Clean Transparency Act (Sen. Klobuchar - not yet introduced) H.R.4413 - National Infrastructure Development Bank Act H.R. 5477 - Federal Agency Climate PREP Act H.R. ____ - Modern Mines Bill (Rep. Lamb - not yet introduced)
2021 · third_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support electrification and electrotechnologies; Grid modernization, including H.R. 1512 - CLEAN Future Act and H.R. 1848 - the LIFT Act; HR 2369, the SMART Electric Act; Reconciliation bills including S. Con. Res. 14 and H.R. 5376- the Build Back Better Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Energy/Nuclear
S.__. - advanced battery manufacturing investment credit and the advanced battery manufacturing production credit. - To be introduced H.R. 998 - Offshore Wind Jobs and Opportunity Act S. 508/ H.R. 1344 - Clean School Bus Act H.R. 2721/ S. 1271- Clean Commute for Kids Act H.R. 1636 - Postal Vehicle Modernization Act S._Sen. Schumer clean bus transit grants (not yet introduced) H.R. ___ - BATTERY Act (not yet reintroduced) H.R.2279 - Office of manufacturing and industrial innovation policy Act H.R. 2369- SMART Electric Act (not yet introduced) S. 1791 - FAST Electricity Act H.R. 2308 - Advanced Technology Vehicle Manufacturing (ATVM) Future Act Electric Drive Act (not yet introduced) H.R. 848 - Growing Renewable Energy and Efficiency Now (GREEN) Act H.R. 1817 - Community Transition Grants Act H.R. 835 - Green Bus Tax Credit Act H.R. 698 - EV CHARGE Act (Doggett) H.R. ___ - Used EV Tax Credit Bill (not yet introduced) H.R. ___ - Driving America Forward Act (soon to be reintroduced in 117th Congress) S. 2118 - Clean Energy for America Act (Plus parts to be reintroduced [45M incentive, etc.] in 117th) S. 622- American Jobs in Energy Manufacturing Act of 2021 S. 2241 - RECHARGE Act (Hickenlooper) S.2140 - Solar Energy Manufacturing for America Act H.R.2263 - Manufacturing for Our Future Act S.2766 Offshore Wind American Manufacturing Act H.R. ____ Sustainable Industry Rebate Program (not yet introduced) S. ___ Hydrogen deployment grant programs (not yet introduced) S.1925 - Buy Green Act S. 1931 - Surface Transportation Reauthorization Act of 2021 (STRA) H.R. _____: Manufacturing Assistance to Determine Emissions (MADE) Act (Rep. Lamb - not yet introduced) S. ____ - Buy Clean Transparency Act (Sen. Klobuchar - not yet introduced) H.R.4413 - National Infrastructure Development Bank Act
Client expense: $50,000 · Firm income: Not reported
2021 · second_quarter · Energy/Nuclear
Issues impacting the energy industry, including infrastructure; support electrification and electrotechnologies; Grid modernization, including H.R. 1512 - CLEAN Future Act and H.R. 1848 - the LIFT Act; HR 2369, the SMART Electric Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $10,000 · Firm income: Not reported
Government targets: Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), White House Office
Government targets: Commerce, Dept of (DOC), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), White House Office